Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: A preliminary study

Drug Delivery

Volumn 22, Issue 4, 2015, Pages 573-580

  Shakeel, Faiyaz ^a,b   Haq, Nazrul ^a,b   Al Dhfyan, Abdullah ^c   Alanazi, Fars K ^b   Alsarra, Ibrahim A ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

5 Fluorouracil; chemoprevention; low HLB surfactant; nanoemulsion; transdermal delivery

Indexed keywords

FLUOROURACIL; SURFACTANT; ANTINEOPLASTIC ANTIMETABOLITE; EMULSION; NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG FORMULATION; HUMAN; HUMAN CELL; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL; RAT; REFRACTION INDEX; SKIN CANCER; SKIN PENETRATION; STEADY STATE; THERMODYNAMICS; VISCOSITY; ZETA POTENTIAL; ANIMAL; CHEMICAL PHENOMENA; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; EMULSION; MELANOMA; PARTICLE SIZE; PROCEDURES; SKIN ABSORPTION; SKIN NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CHEMOPREVENTION; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; FLUOROURACIL; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MELANOMA; NANOPARTICLES; PARTICLE SIZE; RATS; SKIN ABSORPTION; SKIN NEOPLASMS; THERMODYNAMICS;

EID: 84933499638     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.868557     Document Type: Article

References (32)

1. Ahmed M, Ramadan W, Rambhu D, Shakeel F. (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Pharmazie 63:806-11.
2. Alvi IA, Madan J, Kaushik D, et al. (2011). Comparative study of transferosomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in vitro release, and cytotoxicity analysis. Anticancer Drugs 22:774-82.
3. Ammar HO, Salama HA, Ghorab M, Mahmoud AA. (2009). Nanoemulsion as a potential ophthalmic drug delivery system for dorzolamide hydrochloride. AAPS Pharm Sci Tech 10:808-19.
4. Bargman H, Hochman J. (2003). Topical treatment of Bowen's disease with 5-fluorouracil. J Cutan Med Surg 7:101-5.
5. Chauhan A, Zubair S, Sherwani A, Owais M. (2012). Aloe vera induced bimimetic assembalage of nucleobase into nanosized particles. Plos One 7:E32049.
6. Cosco D, Paolino D, Muzzalupo R, et al. (2009). Novel PEG-coated nisomes based on bola-surfactant as drug carriers for 5-fluorouracil. Biomed Microd 11:1115-25.
7. Craig DQM, Barker SA, Banning D. (1995). An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm 114:103-10.
8. Diasio RB, Johnson MR. (2000). The role of pharmacogenetics and pharmacogenomics in cancer chemotherapy with 5-fluorouracil. Pharmacol 61:199-203.
9. Elmaghraby GM. (2008). Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants. Int J Pharm 355:285-92.
10. Elmeshad AN, Tadros MI. (2011). Transdermal delivery of an anticancer drug via w/o emulsions based on alkyl polyglycosides and lecithin: design, characterization and in vivo evaluation of the possible irritation potential in rats. AAPS Pharm Sci Tech 12:1-9.
11. Fang JY, Hung CF, Fang YP, Chan TF. (2004). Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment. Int J Pharm 270:241-9.
12. Freitas C, Muller RH. (1998). Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLNO™) dispersions. Int J Pharm 168:221-9.
13. Gupta RR, Jain SK, Varshney M. (2005). AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of fluorouracil. Coll Surf B 41:25-32.
14. Haq N, Shakeel F, Fars FK, et al. (2013). Development and validation of an isocratic, sensitive and facile RP-HPLC method for rapid analysis of 5-fluorouracil and stability studies under various stress conditions. Asian J Chem 25:7177-82.
15. Hwangl TL, Fang CL, Chen CH, Fang JY. (2009). Permeation enhancer containing water-in-oil nanoemulsions as carriers for intravesical cisplatin delivery. Pharm Res 26:2314-23.
16. Jain N, Akhtar S, Jain GK, et al. (2011). Antiepileptic intranasal amiloride loaded mucoadhesive nanoemulsion: development safety assessment. J Biomed Nanotechnol 7:142-53.
17. Khan GM, Hussain A, Hanif RM. (2011). Preparation and evaluation of 5,9 dimethyl-2-cyclopropyl-2-decanol as a penetration enhancer for drugs through rat skin. Pak J Pharm Sci 24:451-7.
18. Meidan VM, Walmsley AD, Docker MF, Irwin WJ. (1999). Ultrasound-enhanced diffusion into coupling gel during phonophoresis of 5-fluorouracil. Int J Pharm 185:205-13.
19. Rahman Z, Kohli K, Khar RK, et al. (2006). Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS Pharm Sci Tech 7:E47.
20. Raza K, Negi P, Takyar S, et al. (2011). Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies. J Microencapsul 28:190-9.
21. Robins P, Gupta AK. (2002). The use of topical fluorouracil to treat actinic keratosis. Cutis 70:4-7.
22. Shafiq S, Shakeel F, Talegaonkar S, et al. (2007). Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 66:227-43.
23. Shakeel F, Ramadan W, Ahmed MA. (2009). Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics and ex vivo skin permeation studies. J Drug Target 17:435-41.
24. Shakeel F, Ramadan W. (2010). Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Coll Surf B 75:356-62.
25. Shakeel F, Shafiq S, Haq N, et al. (2012). Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview. Expert Opin Drug Deliv 9:953-74.
26. Singh BN, Jayaswal SB. (2008). Iontophoretic delivery of 5-fluorouracil through excised human stratum corneum. Drug Discov Ther 2:128-35.
27. Singh BN, Singh RB, Singh J. (2005). Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int J Pharm 298:98-107.
28. Spernath A, Aserin A, Ziserman L, et al. (2007). Phosphatidylcholine embedded microemulsions: physical properties and improved Caco-2 cell permeability. J Controlled Release 119:279-90.
29. Thomas AM, Kapanen AI, Hare JI, et al. (2011). Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy. J Controlled Release 150:212-9.
30. Yassin AEB, Anwer MK, Mowafy HA, et al. (2010). Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci 7:398-408.
31. Zhang Z, Wo Y, Zhang Y, et al. (2012). In vitro study of ethosome penetration in human skin and hypertrophic scar tissue. Nanomed 8:1026-33.
32. Zhu L, Ma J, Jia N, et al. (2009). Chitosan coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies. Coll Surf B 68:1-6.